NASDAQ:CDLX Cardlytics (CDLX) Stock Price, News & Analysis → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free CDLX Stock Alerts $8.93 -0.08 (-0.89%) (As of 12:22 PM ET) Add Compare Share Share Today's Range$8.87▼$9.2550-Day Range$8.19▼$20.2552-Week Range$4.96▼$20.52Volume325,873 shsAverage Volume1.52 million shsMarket Capitalization$435.61 millionP/E RatioN/ADividend YieldN/APrice Target$12.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Cardlytics alerts: Email Address Cardlytics MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside41.5% Upside$12.75 Price TargetShort InterestHealthy11.48% of Shares Sold ShortDividend StrengthN/ASustainability-0.67Upright™ Environmental ScoreNews SentimentN/AInsider TradingAcquiring Shares$10.96 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.78 out of 5 starsBusiness Services Sector69th out of 311 stocksComputer Programming, Data Processing, & Other Computer Related Industry12th out of 59 stocks 3.4 Analyst's Opinion Consensus RatingCardlytics has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageCardlytics has only been the subject of 3 research reports in the past 90 days.Read more about Cardlytics' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted11.48% of the outstanding shares of Cardlytics have been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cardlytics has recently decreased by 3.11%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldCardlytics does not currently pay a dividend.Dividend GrowthCardlytics does not have a long track record of dividend growth. Previous Next 2.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCardlytics has received a 21.51% net impact score from Upright. Cardlytics seems to create the most significant positive value in categories "Taxes", "Distributing knowledge", and "Jobs". The positive contribution in the "Distributing knowledge" impact category is mostly driven by its "Market intelligence data provision", "Marketing and consumer information services", and "Marketing optimization software" products. See details.Environmental SustainabilityThe Environmental Impact score for Cardlytics is -0.67. Previous Next 2.1 News and Social Media Coverage News SentimentCardlytics has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.48 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cardlytics this week, compared to 2 articles on an average week.Search InterestOnly 10 people have searched for CDLX on MarketBeat in the last 30 days. This is a decrease of -68% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cardlytics insiders have bought 2,308.06% more of their company's stock than they have sold. Specifically, they have bought $10,961,539.00 in company stock and sold $455,203.00 in company stock.Percentage Held by InsidersOnly 4.40% of the stock of Cardlytics is held by insiders.Percentage Held by Institutions68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cardlytics' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardlytics is -2.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardlytics is -2.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardlytics has a P/B Ratio of 2.63. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Cardlytics' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Cardlytics Stock (NASDAQ:CDLX)Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Read More CDLX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDLX Stock News HeadlinesMay 15, 2024 | insidertrades.comInsider Buying: Cardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Acquires 3,746 Shares of StockApril 25, 2024 | insidertrades.comInsider Selling: Cardlytics, Inc. (NASDAQ:CDLX) COO Sells 23,416 Shares of StockMay 14, 2024 | americanbankingnews.comCardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Purchases $33,676.54 in StockMay 14, 2024 | americanbankingnews.comCardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Purchases $1,964,250.00 in StockMay 13, 2024 | americanbankingnews.comCraig Hallum Trims Cardlytics (NASDAQ:CDLX) Target Price to $12.00May 13, 2024 | americanbankingnews.comCardlytics (NASDAQ:CDLX) PT Lowered to $12.00 at Needham & Company LLCMay 10, 2024 | insidermonkey.com5 Best Marketing Stocks to BuyMay 10, 2024 | finance.yahoo.comCardlytics Inc (CDLX) Reports Q1 2024 Earnings: A Detailed AnalysisMay 9, 2024 | fool.comWhy Cardlytics Stock Collapsed on ThursdayMay 9, 2024 | marketwatch.comCardlytics Shares Plummet After Swing to 1Q Loss, Revenue MissMay 9, 2024 | finance.yahoo.comCardlytics, Inc. (NASDAQ:CDLX) Q1 2024 Earnings Call TranscriptMay 9, 2024 | investorplace.comWhy Is Cardlytics (CDLX) Stock Down 29% Today?May 9, 2024 | finance.yahoo.comCardlytics Inc (CDLX) Q1 2024 Earnings Call Transcript Highlights: A Mixed Bag of Growth and ...May 8, 2024 | sfgate.comCardlytics: Q1 Earnings SnapshotMay 8, 2024 | msn.comCardlytics reports mixed Q1 results; initiates Q2 outlookMay 8, 2024 | globenewswire.comCardlytics Announces First Quarter 2024 Financial ResultsMay 2, 2024 | globenewswire.comCardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 30, 2024 | finance.yahoo.comCDLX Jul 2024 9.000 put (CDLX240719P00009000)April 25, 2024 | investing.comCardlytics executive sells over $3.5k in stockApril 24, 2024 | finance.yahoo.comCardlytics Announces Timing of Its First Quarter 2024 Earnings ReleaseApril 19, 2024 | finance.yahoo.comCardlytics, Inc. (CDLX)April 17, 2024 | seekingalpha.comThe Power Of Cardlytics' Data Partnerships Including Bank of AmericaApril 9, 2024 | globenewswire.comLiane Hornsey Appointed to Cardlytics Board of DirectorsApril 9, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Cardlytics Amid Growth Prospects and Strategic American Express PartnershipApril 9, 2024 | markets.businessinsider.comThe Analyst Verdict: Cardlytics In The Eyes Of 5 ExpertsSee More Headlines Receive CDLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2024Today5/21/2024Next Earnings (Estimated)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Computer programming, data processing, & other computer related Sub-IndustryN/A Current SymbolNASDAQ:CDLX CUSIPN/A CIK1666071 Webwww.cardlytics.com Phone(888) 798-5802FaxN/AEmployees434Year Founded2008Price Target and Rating Average Stock Price Target$12.75 High Stock Price Target$18.00 Low Stock Price Target$9.00 Potential Upside/Downside+41.5%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($4.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-134,700,000.00 Net Margins-55.23% Pretax Margin-55.23% Return on Equity-25.36% Return on Assets-8.37% Debt Debt-to-Equity Ratio1.30 Current Ratio2.13 Quick Ratio2.13 Sales & Book Value Annual Sales$309.20 million Price / Sales1.42 Cash Flow$1.29 per share Price / Cash Flow7.00 Book Value$3.43 per share Price / Book2.63Miscellaneous Outstanding Shares48,780,000Free Float46,637,000Market Cap$439.51 million OptionableOptionable Beta1.50 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Karim Temsamani (Age 50)CEO & Director Comp: $917.94kMs. Alexis DeSieno (Age 40)Chief Financial Officer Comp: $565.84kMr. Amit Gupta (Age 51)COO & GM of Bridg Comp: $732.48kMr. Nick Lynton (Age 41)Chief Legal & Privacy Officer and Secretary Comp: $577.42kMr. Peter ChanChief Technology OfficerMr. Peter DaviesHead of Sales Strategy & OperationsMs. Carson NappsHead of PeopleMr. Jose SingerChief Product OfficerMs. Evelyne ForesterChief Business OfficerMore ExecutivesKey CompetitorsRackspace TechnologyNASDAQ:RXTVNET GroupNASDAQ:VNETDada NexusNASDAQ:DADATremor InternationalNASDAQ:TRMREventbriteNYSE:EBView All CompetitorsInsiders & InstitutionsWalleye Trading LLCBought 25,900 shares on 5/17/2024Ownership: 0.000%Jacobs Levy Equity Management Inc.Sold 201,615 shares on 5/16/2024Ownership: 0.460%Blackstone Inc.Bought 140,000 shares on 5/16/2024Ownership: 0.287%Jane Street Group LLCBought 26,700 shares on 5/16/2024Ownership: 0.000%California State Teachers Retirement SystemSold 2,340 shares on 5/16/2024Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions CDLX Stock Analysis - Frequently Asked Questions Should I buy or sell Cardlytics stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CDLX shares. View CDLX analyst ratings or view top-rated stocks. What is Cardlytics' stock price target for 2024? 4 Wall Street analysts have issued 12-month target prices for Cardlytics' stock. Their CDLX share price targets range from $9.00 to $18.00. On average, they predict the company's share price to reach $12.75 in the next year. This suggests a possible upside of 41.5% from the stock's current price. View analysts price targets for CDLX or view top-rated stocks among Wall Street analysts. How have CDLX shares performed in 2024? Cardlytics' stock was trading at $9.21 at the beginning of 2024. Since then, CDLX stock has decreased by 2.2% and is now trading at $9.01. View the best growth stocks for 2024 here. When is Cardlytics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024. View our CDLX earnings forecast. How were Cardlytics' earnings last quarter? Cardlytics, Inc. (NASDAQ:CDLX) issued its quarterly earnings data on Thursday, March, 14th. The company reported ($0.14) earnings per share (EPS) for the quarter. The business had revenue of $89.17 million for the quarter. Cardlytics had a negative trailing twelve-month return on equity of 25.36% and a negative net margin of 55.23%. What ETF holds Cardlytics' stock? Invesco Dorsey Wright Technology Momentum ETF holds 382,812 shares of CDLX stock, representing 0.90% of its portfolio. What guidance has Cardlytics issued on next quarter's earnings? Cardlytics issued an update on its second quarter 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $73.0 million-$81.0 million, compared to the consensus revenue estimate of $81.4 million. What is Lynne Laube's approval rating as Cardlytics' CEO? 26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Glassdoor.com. Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend. What other stocks do shareholders of Cardlytics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Block (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS), Alibaba Group (BABA), Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO). When did Cardlytics IPO? Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. Who are Cardlytics' major shareholders? Cardlytics' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (4.59%), Baillie Gifford & Co. (1.95%), Kent Lake Capital LLC (0.51%), Jacobs Levy Equity Management Inc. (0.46%), Simplex Trading LLC (0.00%) and Perbak Capital Partners LLP (0.33%). Insiders that own company stock include Amit Gupta, Andrew Christiansen, Clifford Sosin, John V Balen, John V Balen, Karim Saad Temsamani, Kirk Somers, Lynne Marie Laube, Nicholas Hollmeyer Lynton, S Aimee Lapic, Scott D Grimes and Scott D Grimes. View institutional ownership trends. How do I buy shares of Cardlytics? Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Cardlytics have any subsidiaries? The following companies are subsidiares of Cardlytics: Bridg, Cardlytics Services India Private Limited, Cardlytics UK Limited, and DOSH.Read More This page (NASDAQ:CDLX) was last updated on 5/21/2024 by MarketBeat.com Staff From Our Partners4 Cryptos BETTER than BitcoinTrue Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport SocietyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardlytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.